Luciferase-based Hematologic Disseminated Tumor Models
Bioluminescence imaging provides a powerful means for quantifying systemic tumor progression in parallel with localized solid tumors, which occur in hematologic tumor models. Licensed access to the extensive Dana Farber Cancer Institute luciferase-expressing panel increases our footprint in many cancer types, including hematologic models.
Cell Tracking Capability
Cell tracking can be achieved using luciferase reporter expression. For example, cell-based therapeutics, including targeting, tissue distribution and viability can be studied in vivo.
Luciferase Reporter Transgenics
An increasingly broad variety of luciferase reporter transgenic mice are commercially available. These transgenics provide opportunities for in vivo optical imaging-based molecular imaging in vivo across a variety of disease states. Contact us for further information about providers and availability of luciferase transgenics.